Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 15.70M | £ 10.50M | £ 11.50M | £ 19.90M | £ 19.60M |
Total Assets | £ 258.70M | £ 195.10M | £ 205.40M | £ 194.80M | £ 211.50M |
Total Debt | £ 70.60M | £ 35.80M | £ 40.40M | £ 53.20M | £ 62.20M |
Net Debt | £ 54.90M | £ 25.30M | £ 28.90M | £ 33.30M | £ 42.60M |
Total Liabilities | £ 221.70M | £ 189.30M | £ 202.10M | £ 200.90M | £ 223.00M |
Stockholders Equity | £ 37.00M | £ 5.80M | £ 3.30M | £ -6.10M | £ -11.50M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |